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Abstract: Glutamine, one of the most abundant amino acids found in maternal milk, favors 
protein anabolism. Early-weaned babies are deprived of this source of glutamine, in a 
period during which endogenous biosynthesis may be insufficient for tissue needs in states 
of metabolic stress, mainly during infections. The objective of this study was to verify the 
effects of dietary glutamine supplementation on the body composition and visceral   
protein status of early-weaned mice inoculated with Mycobacterium bovis Bacillus   
Calmette-Guérin (BCG). Mice were weaned early on their 14th day of life and seperated 
into two groups, one of which was fed a glutamine-free diet (n = 16) and the other a 
glutamine-supplemented diet (40 g/kg diet) (n = 16). At 21 days of age, some mice were 
intraperitoneally injected with BCG. Euthanasia was performed at the 28th day of age. 
BCG inoculation significantly reduced body weight (P < 0.001), lean mass (P = 0.002), 
water (P = 0.006), protein (P = 0.007) and lipid content (P = 0.001) in the carcass. Dietary 
glutamine supplementation resulted in a significant increase in serum IGF-1 (P = 0.019) 
and albumin (P = 0.025) concentration, muscle protein concentration (P = 0.035) and lipid 
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content (P = 0.002) in the carcass. In conclusion, dietary glutamine supplementation had a 
positive influence on visceral protein status but did not affect body composition in   
early-weaned mice inoculated with BCG. 
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1. Introduction 
Weaning (the period in which infants transition from a diet of milk to other food) is when infants 
are at the highest risk of malnutrition, infections, and growth faltering [1]. Glutamine and glutamate 
are the most abundant amino acids found in proteins and in human milk, as well as in rat and mouse 
milk [2,3]. Furthermore, as human lactation progresses, glutamine and glutamate increase approximately 
20 and 2.5 times, respectively, representing more than 50% of all free amino acids in human milk  
by the third month of lactation [4]. On average only about 35% of infants 0 to 6 months old are 
exclusively breastfed [5]. Exclusive breastfeeding is rarely sustained, and often supplemented with 
other formula or other complementary foods. In contrast to infants fed with maternal milk, premature 
or early-weaned infants are deprived of this glutamine source, which renders them exclusively 
dependent on endogenous synthesis of this amino acid or on supplementation by means of 
commercially available formulations for babies [4]. 
The high concentration of glutamine in maternal milk may be related to the role of this amino acid 
in the metabolism of rapidly dividing cells such as enterocytes and leucocytes [6]. Within this context, 
Rogero et al. [7–9] showed that a lack of glutamine intake associated with early weaning hinders the 
functionality of peritoneal macrophages, an effect which could be partially reversed by glutamine 
ingestion. Furthermore, glutamine supplementation reduces the incidence of infectious morbidity in 
preterm and low-birth-weight neonates [10,11]. 
Glutamine is considered a conditionally essential amino acid in catabolic stress states [12], when 
muscle stores of glutamine become depleted [13]. There is evidence that glutamine supplementation 
may influence nitrogen balance and prognosis in some critical patients [14,15]. In addition, dietary 
glutamine supplementation in rodents reversed the reduction in muscle and liver protein and DNA 
concentration induced by early weaning [8]. Since the effect of glutamine supplementation on protein 
balance and body composition of early-weaned animals under situations of metabolic stress is 
unknown, the present study aimed to investigate the effects of dietary glutamine supplementation on 
the body composition and visceral protein status, as defined by serum albumin and IGF-1 levels,   
of early-weaned mice inoculated with Mycobacterium bovis Bacillus Calmette-Guérin (BCG), a 
weakened strain of Mycobacterium bovis used as a vaccine against tuberculosis, which promotes a 
inflammatory response [16], as well as an increase in body protein catabolism [17] in rodents. To date, 
studies relating BCG and glutamine have evaluated only the effect of glutamine supplementation  
in vitro on the function of peritoneal macrophages activated with BCG, as well as on the pattern of 
cytokine production from peripheral blood mononuclear cells [18–20]. Nutrients 2011, 3  
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2. Experimental Section 
Mice and treatments. Male Swiss Webster mice obtained from the Animal Laboratory of the 
Faculty of Pharmaceutical Sciences at the University of São Paulo were weaned at 14 day of age. The 
mice were kept in a room at an ambient temperature of 22 ± 2 °C and a relative humidity of 55 ± 10% 
under a 12-h light/12-h dark cycle (lights on at 0700). The mice were weighed daily and their final 
mass was recorded immediately before sacrifice. 
All mice were generated by mating two 2-month-old primiparous females with a single male. After 
pregnancy was confirmed, the females (n = 8) were maintained isolated in individual cages throughout 
gestation. After the birth of their offspring, eight males were chosen and then maintained with their 
mother during the next 14 day. At the time of weaning (at the age of 14 day), 32 baby mice, 4 from 
each female, were distributed into two groups: 16 of them were fed a glutamine-free diet (−Gln),  
while the other 16 were fed a glutamine-supplemented diet (+Gln). Mice of the −Gln (n = 16) and 
+Gln (n = 16) groups were fed ad libitum with water and a diet made specifically for infant mice, 
according to the American Institute of Nutrition (AIN-93G) [21] from day 14 to day 28 (Table 1). It is 
important to emphasize that 14 day old mice are able to process solid food. In order to ensure that the 
diet was glutamine-free, a casein substitute was formulated using a mixture of amino acids without 
glutamine (Ajinomoto Interamericana Indústria e Comércio Ltda, São Paulo, Brazil) in similar 
quantities to those found in casein (Table 2). The amount of nitrogen corresponding to the withdrawal 
of glutamine (3.33 g nitrogen/kg diet) was substituted with the dispensable amino acids alanine, 
aspartic acid, glycine, proline and serine. Mice from the +Gln group were also fed a casein-free diet, 
which was supplemented by the addition of each one of the amino acids present in casein plus 
additional glutamine (40 g glutamine/kg diet). This dose of glutamine was chosen based on some 
studies [22–24].  
Table 1. Diet compositions 
1,2. 
Ingredient   −Gln diet   +Gln diet  
 g/kg  diet 
Cornstarch 542.4  562.1 
Amino acid mixture  190.1  170.4 
Sucrose 100  100 
Soybean oil  70  70 
Fiber source (cellulose)  50  50 
Mineral mixture 
3,4 35  35 
Vitamin mixture 
5 10  10 
Choline bitartrate (41.1% choline)  2.5  2.5 
tert-Butylhydroquinone 0.014  0.014 
1 Based on AIN-93G [21]; 
2 Both diets (−Gln and +Gln) are isocaloric (1674 kJ/100 g) and 
isonitrogenous (2.45 g nitrogen/100 g); 
3 Due to the removal of casein from the formulation of  
the diet, the mineral mixture was enriched with a 180.68 g potassium phosphate/kg mix, resulting 
in the supply of 3 g phosphorus/kg diet; 
4 AIN-93G [21] mineral mixture; 
5 AIN-93G [21] 
vitamin mixture. Nutrients 2011, 3  
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Table 2. Amino acid profiles of the diets 
1. 
Amino acid  −Gln diet  +Gln diet 
 g/kg  diet 
Nonessential    
L-Ala 8.8  2.6 
L-Asp 18.5  3.9 
L-Glu 18.9  18.9 
Gly 6.8  2.2 
L-Gln -  40.0 
L-Pro 26.0  3.4 
L-Ser 14.7  3.1 
NEAA-N 
2 11.52  11.52 
Essential    
L-Arg 6.4  6.4 
L-Cys 3.7  3.7 
L-Phe 8.8  8.8 
L-His 4.6  4.6 
L-Ile 8.5  8.5 
L-Leu 15.4  15.4 
L-Lys 16.2  16.2 
L-Met 4.6  4.6 
L-Thr 6.7  6.7 
L-Tyr 9.3  9.3 
L-Trp 2.1  2.1 
L-Val 10.0  10.0 
EAA-N 
2 12.94  12.94 
NEAA-N:EAA-N ratio, g:g  1.12  1.12 
1 Based on the composition of amino acids present in the AIN-93G diet [21]; 
2 NEAA-N, 
nonessential amino acid nitrogen; EAA-N, essential amino acid nitrogen. 
At 21 day of age, eight mice from the −Gln group and eight mice from the +Gln group were 
intraperitoneally inoculated with 10
7 viable units of BCG, Mycobacterium bovis cepa Moreau, 
provided by the Butantan Institute (Sao Paulo, SP, Brazil). Thus, the study was performed with 
four experimental  groups:  −Gln/−BCG (n = 8), −Gln/+BCG (n = 8), +Gln/−BCG (n = 8) and 
+Gln/+BCG (n = 8). 
On day 28, the mice from the four groups were intraperitoneally anesthetized with ketamine 
hydrochloride (100 mg/kg body mass) in combination with xylazine hydrochloride (50 mg/kg body 
mass) and then killed by the cervical dislocation method. All of the mice were sacrificed in the 
morning between 0800 and 1200. Blood, spleen, liver, and muscle tissue from the gastrocnemius were 
collected for analyses. All procedures carried out on mice were approved by the Ethics Committee  
on Animal Experimentation of the Faculty of Pharmaceutical Sciences, University of Sao Paulo   
(3 June 2003; protocol number 14), according to the guidelines on Animal Experimentation of the 
Brazilian College.  Nutrients 2011, 3  
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2.1. Serum Determinations 
Serum albumin concentration was assayed by the bromocresol green method [25]. Serum protein 
and iron concentration was measured according to the methods of Biuret [26] and Goodwin [27], 
respectively, using commercial kits (CELM, São Paulo, Brazil; Labtest Diagnostica SA, São Paulo, 
Brazil). Serum corticosterone and IGF-1 concentration was measured with a commercially available 
radioimmunoassay kit (DSL, Diagnostic Systems Laboratories, Inc., Webster, TX, USA). The 
radioactivity was determined in a gamma counter (Beckman L600). The mice used for the 
determination of the serum concentration of corticosterone were sacrificed using a guillotine, in order 
to minimize any alteration in the serum concentration of corticosterone induced by the use of 
anesthetics. The plasma glutamine concentration was determined according to the method described by 
Lund [28], based on the enzymatic conversion of NAD
+ to NADH, which is directly proportional to 
the initial glutamine content.  
2.2. Tissue Determinations 
Muscle glutamine was extracted as described by Sahlin et al. [29]; frozen samples were pulverized, 
homogenized in cold perchloric acid (PCA) (0.5 M) and centrifuged (3000 rpm, 4 °C, 15 min). 
Supernatant was neutralized with sodium bicarbonate (0.5 M) and used for glutamine determination as 
described by Lund [28]. The maximal activity of the enzyme glutamine synthetase (GS) in the liver 
was determined according to Minet et al. [30]. Briefly, liver was homogenized in a solution containing 
50 mM of imidazole. After centrifugation, the supernatant was used for the enzymatic assay. The assay 
mixture consisted of 50 mM imidazole (pH 6.8), 50 mM L-glutamine, 25 mM hydroxylamine, 25 mM 
sodium arsenate, 2 mM manganese chloride and 0.16 mM diphosphate adenosine. After 30 min 
incubation at 37 °C, reaction was blocked, samples centrifuged and absorbance was measured at 
540 nM. For the extraction of protein and RNA, tissue samples were pulverized, homogenized in 
trichloroacetic acid 10%, and centrifuged (3000 rpm, 4 °C, 15 min). The pellet was resuspended in 
cold PCA 2% and centrifuged (3000 rpm, 4 °C, 15 min). The resulting pellet was resuspended in 
sodium hydroxide (0.3 N) and incubated at 37 °C for 1 h. After this period, an aliquote of this solution 
was used for the determination of protein according to the method described by Lowry et al. [31]. Cold 
PCA 20% was added to the remaining solution, which was incubated on ice for 10 min, and, then, 
centrifuged (3000 rpm, 4 °C, 15 min). The supernatant was used for the determination of RNA in the 
tissues according to the method described by Munro and Fleck [32].  
2.3. Body Composition Determination 
The body composition of the animals (fat, protein, humidity, and ashes) was determined by 
chemical analysis of the carcass. Humidity content was determined by drying the whole carcass in a 
ventilated oven (70 °C) for 7 day. Carcasses were weighed before being placed in the oven and after 
being dried, and the difference between measurements was considered to be the absolute humidity 
content. The whole dry carcass was then chopped up and wrapped in gauze and filter paper for 
determination of body fat by the solvent extraction technique using a Soxhlet apparatus and ethyl ether 
as solvent. The remaining carcass without humidity and fat was completely ground (IKA M20 grinder, Nutrients 2011, 3  
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Labortechnik, Wasserburg, Germany) and sieved for the removal of hair, which could decrease the 
homogeneity of the sample. This process resulted in a highly homogenous powder that was used to 
determine carcass protein by the micro-Kjeldahl method [33] and ash content. Two grams of powder 
was placed in a muffle furnace for 12 h at 550 °C and then cooled, and the ash weight of the sample 
was determined. The amount of lean mass was calculated by subtracting absolute fat mass from total 
carcass mass. Fat, protein, humidity, ash, and lean mass contents were also calculated in percentages in 
relation to carcass mass. 
2.4. Statistical Analyses 
Initial body weight was expressed as means (Pooled SD) and analyzed by one-way ANOVA after 
checking the homogeneity of variances using a Bartlett test. The Tukey HSD was applied to compare 
means. The effects of glutamine supplementation (diet) and inoculation with BCG were expressed as 
means followed by Pooled SD and analyzed by factorial ANOVA (2
2) followed by a Tukey HSD test. 
Probability values of P < 0.05 indicated statistical significance. Calculations were performed using 
Statistica version 7.1 (StatSoft Inc., Tulsa, OK, USA). 
3. Results 
Mean daily diet intakes (3.2 ± 0.5 g) were not different among groups. Despite the fact that the 
initial body weight (8.2 ± 0.7 g) did not differ among groups, BCG inoculation significantly reduced 
(P < 0.001) final body weight (−BCG = 18.6 ± 0.4 g; +BCG = 16.0 ± 0.6 g). BCG inoculation also 
significantly decreased serum iron concentration (P < 0.001). The glutamine-supplemented diet resulted 
in an increase in serum IGF-1 (P = 0.019) and albumin (P  = 0.025) concentration, serum IGF-1 
concentration being higher in the +Gln/+BCG group compared to the −Gln/+BCG group (Table 3). 
Serum corticosterone and total protein concentration were not affected by either diet or BCG 
inoculation. The plasma glutamine concentration tended to be greater (P = 0.054) in the +Gln groups 
than in the −Gln groups but was not affected by BCG. 
BCG inoculation had a marked effect on body composition, since it significantly decreased carcass 
mass (P  < 0.001), lean mass (P  = 0.002), and water (P  = 0.006), protein (P  = 0.007) and lipid   
(P  = 0.001) content, while glutamine supplementation increased the lipid content of the carcass   
(P = 0.002) (Table 4). BCG inoculation led to a significant reduction in muscle weight (P = 0.041) and 
liver RNA concentration (P = 0.021) and a significant increase in spleen weight (P < 0.001) and the 
liver (P = 0.008) and muscle (P = 0.018) protein:RNA ratio. Glutamine supplementation increased 
liver weight (P  = 0.032) and muscle protein concentration (P  = 0.035). Muscle glutamine 
concentration and the maximal activity of GS in the liver were not affected by either diet or BCG 
inoculation (Table 5). 
 Nutrients 2011, 3  
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Table 3. Plasma/serum variables of 28-day-old rats weaned to glutamine-supplemented (+Gln) or glutamine-free (−Gln) diets at 14 days of 
age and intraperitoneally injected (+BCG) or not injected (−BCG) with BCG at 21 days of age. São Paulo, 2007. 
 Experimental  Groups   
Variable 
1  −Gln −BCG –Gln +BCG +Gln −BCG +Gln +BCG Pooled SD  Diet 
2 Infection 
2  Diet × Infection 
2 
Serum albumin (g/dL)  3.26  3.23  3.44  3.39  0.04  0.025  0.537  0.892 
Serum total protein (g/dL)  4.11  4.27  4.34  4.19  0.05  0.487  0.994  0.140 
Plasma glutamine (μmol/L)  0.52 0.52 0.57 0.58 0.01  0.054  0.890  0.781 
Serum iron (µg/dL)  231.0  155.3  210.4  152.1  8.5  0.413  <0.001  0.548 
Serum IGF-1 (ng/mL)  277.5  173.8  274.7  333.7  18.5  0.019  0.480  0.016 
Serum corticosterone (ng/mL)  92.5  94.9  112.3  96.5  6.2  0.659  0.387  0.299 
1 Values are means and variation of the groups is expressed as pooled SD, n = 8; 
2 Probability values obtained by factorial ANOVA.  
Table 4. Mass and chemical composition of the carcasses of 28-day-old rats weaned to glutamine-supplemented (+Gln) or glutamine free  
(−Gln) diets at 14 days of age and intraperitoneally injected (+BCG) or not injected (−BCG) with BCG at 21 days of age. São Paulo, 2007. 
 Experimental  Groups   
Variable 
1  −Gln −BCG  −Gln +BCG  +Gln –BCG  +Gln +BCG  Pooled SD  Diet 
2 Infection 
2  Diet × Infection 
2 
Carcass mass (g)  18.38  16.16  19.81  16.08  2.57  0.359  <0.001  0.302 
Lean mass (g)  16.96  14.10  16.87  14.25  2.27  0.966  0.002  0.880 
Humidity  (g)  11.59 10.62 12.71 10.51 1.78  0.365  0.006  0.271 
Protein (g)  3.34  2.93  3.34  2.77  0.55  0.619  0.007  0.644 
Fat (g)  1.28  1.09  1.77  1.23  0.36  0.002  0.001  0.076 
Ashes (g)  0.80  0.66  0.79  0.65  0.23  0.937  0.088  0.979 
1 Values are means and variation of the groups is expressed as pooled SD, n = 8; 
2 Probability values obtained by factorial ANOVA. Nutrients 2011, 3  
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Table 5. Tissue weights, RNA, and protein concentration of 28-day-old rats weaned to glutamine-supplemented (+Gln) or glutamine free  
(−Gln) diets at 14 days of age and intraperitoneally injected with BCG (+BCG) or not (−BCG) at 21 days of age. São Paulo, 2007. 
 Experimental  Groups   
Variable 
1  −Gln −BCG −Gln +BCG  +Gln −BCG +Gln +BCG Pooled SD  Diet 
2 Infection 
2 Diet × Infection 
2 
Liver  (g)  1.03 1.07 1.17 1.17  0.05  0.032  0.685  0.602 
Gastrocnemius  Muscle  (g)  0.071 0.070 0.085 0.067  0.010  0.175  0.041  0.055 
Spleen  (g)  0.12 0.27 0.14 0.29  0.08  0.321  <0.001 0.894 
Liver Protein (mg/100 mg tissue)  12.87  13.35  13.52  13.52  0.88  0.436  0.329  0.426 
Muscle Protein (mg/100 mg tissue)  14.15  14.01  14.34  15.93  0.27  0.035  0.137  0.082 
Spleen Protein (mg/100 mg tissue)  12.80  13.63  14.45  13.42  1.28  0.188  0.846  0.093 
Liver Protein/RNA ratio  0.013  0.015  0.013  0.014  0.00  0.458  0.008  0.584 
Muscle Protein/RNA ratio  0.051  0.060  0.057  0.063  0.01  0.336  0.018  0.804 
Spleen Protein/RNA ratio  0.013  0.015  0.014  0.014  0.00  0.940  0.573  0.606 
Liver RNA (µg/g fresh tissue)  1,023  913  1,076  977  107.88  0.186  0.021  0.977 
Muscle RNA (µg/g fresh tissue)  278  242  254  254  31.89  0.750  0.144  0.177 
Spleen RNA (µg/g fresh tissue)  991  940  1,080  984  105.20  0.179  0.136  0.373 
Muscle glutamine  
(µmol glutamine/g fresh tissue) 
3.91 3.94 4.16 3.76  0.12  0.904  0.453  0.389 
Liver Glutamine synthetase 
(nmol/h/mg protein) 
1,294 862 1,195 933 465  0.934  0.050  0.618 
1 Values are means and variation of the groups is expressed as pooled SD, n = 8; 
2 Probability values obtained by factorial ANOVA. 
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4. Discussion 
Glutamine is a conditionally essential amino acid because of the body’s inability to synthesize 
sufficient amounts to keep up with the demands during acute stress situation [34,35]. In the present 
study, we investigated the effect of dietary glutamine supplementation on the body composition and 
visceral protein status of early-weaned mice inoculated with BCG. Glutamine supplementation in 
rodents is usually done through diet or by intragastric administration. Nevertheless, in this study, 
intragastric administration would result in serious problems of administration of glutamine, due to  
the small size of the animals. At the same time, several published studies show that glutamine 
supplementation through the diet is effective in promoting beneficial effect on the immune response 
and reduction of mortality rate [22–24]. 
Dietary glutamine supplementation for 14 days significantly improved visceral protein status in 
early-weaned mice inoculated with BCG. Within this context, glutamine supplementation increased 
serum IGF-1 and albumin concentration. Serum IGF-1 concentration is a widely used biomarker for 
nutritional status assessment; since it is sensitive to diet composition and protein content [36]. Low 
protein intake may decrease serum IGF-1 concentration, which seems to be related to reductions in 
liver IGF-1 mRNA content [37]. Additionally, Takenaka et al. [38] showed that dietary restriction of 
single essential amino acids reduces serum IGF-1 concentration. In the present study, diets were 
isonitrogenous and had the same essential-to-nonessential amino acid ratio. Since there were no 
differences in diet consumption among groups, it is suggested that glutamine might be involved in the 
modulation of IGF-1 metabolism in early-weaned animals under metabolic stress. 
IGF-1 promotes muscle protein synthesis, which contributes to a positive protein balance [39]. 
Accordingly, the higher muscle protein concentration observed in the +GLN/+BCG group compared  
to −GLN/+BCG group might be related to the increase in serum IGF-1 concentration induced by 
glutamine supplementation. It is also important to emphasize that glutamine may influence muscle 
protein balance directly. The increase in intramuscular glutamine concentration inhibits proteolysis in 
the muscle [40]. Apart from this effect, there is a positive relationship between the protein synthetic 
rate and muscle glutamine concentration up to the limit of the expansion of the intramuscular 
glutamine pool [41]. Wu and Thompson [42] found that elevating extracellular glutamine concentration 
from 1 mM to 15 mM augmented protein synthesis and decreased protein degradation in incubated 
chicken skeletal muscle. Nevertheless, since muscle glutamine concentration was not different among 
groups in the present study, it is suggested that glutamine supplementation had an indirect influence on 
muscle protein balance, increasing serum IGF-1 concentration.  
Despite its influence on visceral protein status, dietary glutamine supplementation did not raise 
glutamine concentration in plasma. This lack of effect of dietary glutamine supplementation on plasma 
glutamine concentration has been reported by other studies [22]. One of the possible mechanisms 
involved is the higher cellular uptake of glutamine when its availability in the bloodstream increases. 
According to Parry-Billings and Newsholme [43], the rise in plasma glutamine concentration induced 
by its ingestion increases muscle glutamine uptake and in consequence decreases glutamine release 
into circulation. Furthermore, some authors suggest that this limited effect of dietary glutamine 
supplementation probably reflects its utilization by enterocytes and hepatocytes [44].  Nutrients 2011, 3  
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It is well established that infectious diseases may impair growth and nutritional status. In the 
present study, BCG inoculation reduced body weight, lean mass, water, protein and fat content in the 
carcass. These results are related to the catabolic status induced by infection, which is mostly mediated 
by proinflammatory cytokines such as tumor necrosis factor-α [45,46]. The host responds to infection 
by activating its defense systems and concomitantly by mobilizing body proteins, supplying the 
organism with amino acids in order to meet the hypermetabolic demand induced by the infection. In 
growing animals, this process leads to a negative nitrogen balance and loss of body proteins [47]. It is 
also important to emphasize that dietary glutamine supplementation failed to reverse the detrimental 
effects on body composition of BCG inoculation. Nevertheless, glutamine-supplemented mice had 
higher fat mass when compared to control animals. This result can be attributed to the fact that 
glutamine carbon is utilized as a precursor for lipid synthesis in adipocytes [48]. Fatty acids produced 
from glutamine are incorporated into triacylglycerol in incubated adipocytes [49]. Recently, 
Rumberger et al. [50] showed that glutamine (16 mM) potentiated the glucose-dependent increase  
in fatty acid synthase (FAS) and glycerophosphate dehydrogenase (GPDH) mRNA in cultured   
primary rat adipocytes. These authors suggested that products of glutamine metabolism, such as 
glucosamine-6-phosphate, were important for glucose regulation of FAS and GPDH.  
5. Conclusion 
In conclusion, the present results demonstrate that dietary glutamine supplementation had a positive 
influence on visceral protein status, but did not affect body composition in early-weaned mice 
inoculated with BCG. 
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